Asthma, Peanut Allergy Products Could Get Boost From FDA Advisory Panel
This article was originally published in The Pink Sheet Daily
Executive Summary
Topics are general clinical development issues for immunotherapies targeted at food allergies and respiratory allergic diseases, but recommendations could help move specific products forward for several firms.